ArticleVirchows Archiv : an international journal of pathology2013

Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases.

Petr Steiner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.